Overview
Emma Bolderson practices in Brisbane, Australia. Ms. Bolderson is rated as an Advanced expert by MediFind in the treatment of Progeria. Her top areas of expertise are Progeria, Triple-Negative Breast Cancer, Lung Cancer, and Xeroderma Pigmentosum.
Her clinical research consists of co-authoring 42 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 3 articles in the study of Progeria.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- ProgeriaMs. Bolderson isAdvanced. Learn about Progeria.
- Experienced
- Ataxia-TelangiectasiaMs. Bolderson isExperienced. Learn about Ataxia-Telangiectasia.
- Lung CancerMs. Bolderson isExperienced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Ms. Bolderson isExperienced. Learn about Non-Small Cell Lung Cancer (NSCLC).
- TelangiectasiaMs. Bolderson isExperienced. Learn about Telangiectasia.
- Triple-Negative Breast CancerMs. Bolderson isExperienced. Learn about Triple-Negative Breast Cancer.
- Xeroderma PigmentosumMs. Bolderson isExperienced. Learn about Xeroderma Pigmentosum.